Tech Stocks emergin...
Health Care: Drugs
Agenus Inc. (AGEN: NASDAQ)
$3.78 0.03 | 0.80%
06/18/13 - 04:00 PM ET
738.91K / 195.90K
Vol / Avg. Vol:3.77 / 3.75
Open / Prev. Close:3.67 - 4.20
Today's Range:3.37 - 5.47
52 Wk Range:-8.54%
Performance YTD:TheStreet Rating:
Portfolios with AGEN
- Portfolio NameUser Type
- UserKJP Save Stockpickr Fund
- ContributorStocks Under-$10 Moving Hig...
- ProRobert Bruce
- Contributor16 Small-Cap Stocks in Dang...
- UserASCO 2010
- Userhp22puch Portfolio 1
- Usernvoelz Portfolio 1
- UserPix's Stocks
- UserArsenD Portfolio 1
- UserMikejo10 Portfolio 1
Latest AGEN Headlines from TheStreet
- Agenus To Report First Quarter 2013 Financial Results On April 24, 2013; Conference Call To Follow 04.18.13 | 07:04 am
- Agenus Eliminates Its $39 Million Senior Notes And Completes $10 Million Of New Debt Financing 04.16.13 | 07:04 am
- Agenus' Brain Cancer Vaccine Results To Be Presented At Plenary Session Of The 81st American Association Of Neurological Surgeons (AANS) Annual Scientific Meeting 04.10.13 | 07:04 am
- Agenus To Present At The ROTH Annual Conference 03.14.13 | 02:03 pm
- Agenus Reports Fourth Quarter And Year End 2012 Financial Results 02.28.13 | 07:02 am
- Agenus' HerpV Phase 2 Study To Treat Genital Herpes Completes Enrollment 02.27.13 | 07:02 am
- Agenus To Present At Cowen And Company Annual Healthcare Conference 02.26.13 | 09:02 am
- Agenus To Report Fourth Quarter And Year End 2012 Financial Results On February 28, 2013; Conference Call To Follow 02.21.13 | 07:02 am
- Agenus To Present At BIO CEO & Investor Conference 02.06.13 | 08:02 am
- Agenus To Present At OneMedForum San Francisco 2013 01.02.13 | 03:01 pm
Press Releases for AGEN
- Aeras Signs Agreement With GSK To Jointly Advance TB Vaccine - PR Newswire 10.10.12 | 12:10 am
- The Fourth Product Candidate Containing Antigenics' QS-21 In Phase 3 Clinical Development - Business Wire 08.25.10 | 02:08 pm
- Antigenics Reports Second Quarter 2010 Financial Results - Business Wire 07.29.10 | 07:07 am
- Antigenics Presents Positive, Top Line Data From Phase I Herpes Clinical Trial - Business Wire 07.27.10 | 07:07 am
- Antigenics To Report Second Quarter Financial Results On July 29, 2010; Conference Call To Follow - Business Wire 07.22.10 | 07:07 am
- Antigenics Receives NASDAQ Delisting Notification - Business Wire 07.21.10 | 04:07 pm
- Encouraging Data Presented On Oncophage® Vaccine At International Conference On Brain Tumor Research And Therapy - Business Wire 05.20.10 | 07:05 am
- Antigenics To Webcast 2010 Annual Shareholders Meeting - Business Wire 04.29.10 | 07:04 am
- Antigenics Reports First Quarter 2010 Financial Results - Business Wire 04.29.10 | 07:04 am
- Antigenics To Report First Quarter Financial Results On April 29, 2010; Conference Call To Follow - Business Wire 04.22.10 | 07:04 am
Partner Headlines for AGEN
- Zacks #1 Rank Additions for Thursday - Tale of the Tape - Zacks 12.06.12 | 09:12 am
- Zacks #1 Rank Additions for Tuesday - Tale of the Tape - Zacks 12.04.12 | 09:12 am
- Zacks #1 Rank Additions for Tuesday - Tale of the Tape - Zacks 11.27.12 | 09:11 am
- Zacks #1 Rank Additions for Tuesday - Tale of the Tape - Zacks 11.13.12 | 09:11 am
- Zacks #1 Rank Additions for Thursday - Tale of the Tape - Zacks 11.01.12 | 09:11 am
- Zacks #1 Rank Additions for Friday - Tale of the Tape - Zacks 10.26.12 | 09:10 am
- Pre-Market Earnings Report for August 2, 2012 : APA, AEE, ANSS, ARIA, APO, ALE, AB, ABMD, AYR, AVD, ARQL, AGEN - NASDAQ 08.01.12 | 08:08 pm
- Agenus Inc: More Than Just A Stimulon Play - Seeking Alpha 07.19.12 | 09:07 am
- Zacks #1 Rank Additions for Thursday - Tale of the Tape - Zacks 05.17.12 | 09:05 am
- Zacks #1 Rank Additions for Monday - Tale of the Tape - Zacks 05.14.12 | 09:05 am
